Dr. John Cush RheumNow
5 years 11 months ago
Shifting Treatment Paradigms in Psoriatic Arthritis: Dr. Eric Ruderman (@JointMD)
Chicago-based Dr. Eric Ruderman discussed the shifting treatment paradigms in psoriatic arthritis by reviewing abstracts #0504 and #2026 at #ACR20.
https://t.co/jsLkgWG63v https://t.co/h3r2oapOij
David Liew drdavidliew
5 years 11 months ago
Nintedanib in rheum ILD (RA/SSc/CTD)
I appreciate the volumes might not seem like much, but:
- in first 1y Rx 20% more are spared a FVC decline>10%
- biggest diff in UIP-like pattern
With the right patient selection, nintedanib does have its place!
#ACR20 ABST1048/1049 @RheumNow https://t.co/jGZdR84bBU
Mrinalini Dey DrMiniDey
5 years 11 months ago
Time-trends analysis of in-hospital mortality in #vasculitis in the US shows it to have significantly declined in this population from 1998 to 2014.
Abs#1423 #ACR20 @RheumNow
https://t.co/TTI4DJiCRk
Eric Dein ejdein1
5 years 11 months ago
Corkscrew hairs and swollen knee - what's your diagnosis? TM01 #ACR20 @RheumNow https://t.co/jOkI94AKr6
alexa meara lexmeara
5 years 11 months ago
Please take the new telemedicine survey- how can we help our patients during these unique times! @RheumNow #ACR20 https://t.co/n2jFfh1N9N
alexa meara lexmeara
5 years 11 months ago
So much more work to be done- the traditional tools for estimating CVD in rheumatic patients are likely not accurate especially patients with SLE- abstract 1286 @RheumNow #acr20 https://t.co/L6Z1fsO2he
Dr. Rachel Tate uptoTate
5 years 11 months ago
#ABS1303 shows ASAS modification of Berlin algorithm showed optimal balance between sensitivity and specificity and represented the preferred referral strategy for patients presenting w/ undiagnosed back pain & extra-articular features. #ACR20 @RheumNow https://t.co/10VdKC3E75 https://t.co/RgC7K3V8TB
Mrinalini Dey DrMiniDey
5 years 11 months ago
Patients diagnosed w/ #ANCA #vasculitis aged >75yrs have lower risk of relapse than pts 65-75yrs. Pts >75yrs less likely to be treated w/ immunosuppression & steroids but do benefit from this treatment when it is required.
Abs#1417 #ACR20 @RheumNow
https://t.co/stTAcioiQG
Eric Dein ejdein1
5 years 11 months ago
Excellent case - great job! @RheumNow #ACR20 #TM05 https://t.co/obE7KLD68m
Richard Conway RichardPAConway
5 years 11 months ago
Dr @AliDuarteMD presents on incidence of SLE over last 40 years, 29% increase overall, and doubled in males. Overall cyclical pattern. Abstr#1024 #ACR20 @rheumnow https://t.co/SSVY0U0SIg
Sole RetamozoSole
5 years 11 months ago
#sjogren #syndrome poster session #ACR20 @RheumNow Clinical characteristics: lung, pregnancy,smoking, cervical lesions, anti La, childhood. https://t.co/QN4FVvQrYN
Eric Dein ejdein1
5 years 11 months ago
Great Thieves Market poster by my @jhrheumatology co-fellow Dr. James Son. 27 yo patient with active myositis has this imaging. Check it out for diagnosis! @RheumNow #ACR20 https://t.co/xUT6QkWNAX
Improving Response to Pegloticase: Dr. Nicola Dalbeth
Auckland-based rheumatologist Dr. Nicola Dalbeth discusses improving responses to the use of Pegloticase, including abstracts #0677 and #0952.
Nomenclature, Uveitis and Other Spondyloarthritis Features: Dr. Lianne Gensler
Dr. Gensler reviews her top selections for ACR 2020 today, including abstract #0881 and #0876. She also highlighted the study group on spondyloarthritis, which focused on nomenclature.
Dr. John Cush RheumNow
5 years 11 months ago
The RheumNow podcast on #ACR20 Day 2 Part I is now available for download. Follow the link below to listen in or find us on Apple.
https://t.co/VAPnzYtCIK https://t.co/kD4lNltMsw
